These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target. Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628 [TBL] [Abstract][Full Text] [Related]
25. The non-haematopoietic biological effects of erythropoietin. Arcasoy MO Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962 [TBL] [Abstract][Full Text] [Related]
26. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Wang L; Di L; Noguchi CT Int J Biol Sci; 2014; 10(8):921-39. PubMed ID: 25170305 [TBL] [Abstract][Full Text] [Related]
27. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis. Gombos Z; Danihel L; Repiska V; Acs G; Furth E Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073 [TBL] [Abstract][Full Text] [Related]
28. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression. Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin, erythropoiesis and beyond. Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802 [TBL] [Abstract][Full Text] [Related]
30. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043 [TBL] [Abstract][Full Text] [Related]
31. Production and processing of erythropoietin receptor transcripts in brain. Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of erythropoietin expression in human endometrial carcinoma. Acs G; Xu X; Chu C; Acs P; Verma A Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341 [TBL] [Abstract][Full Text] [Related]
33. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions? Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion. Doleschel D; Rix A; Arns S; Palmowski K; Gremse F; Merkle R; Salopiata F; Klingmüller U; Jarsch M; Kiessling F; Lederle W Theranostics; 2015; 5(8):905-18. PubMed ID: 26000061 [TBL] [Abstract][Full Text] [Related]
35. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised? Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933 [TBL] [Abstract][Full Text] [Related]
36. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
37. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity. Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914 [TBL] [Abstract][Full Text] [Related]
38. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940 [TBL] [Abstract][Full Text] [Related]
39. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106 [TBL] [Abstract][Full Text] [Related]
40. Survival and invasiveness of astrocytomas promoted by erythropoietin. Mohyeldin A; Dalgard CL; Lu H; Mcfate T; Tait AS; Patel VC; Wong K; Rushing E; Roy S; Acs G; Verma A J Neurosurg; 2007 Feb; 106(2):338-50. PubMed ID: 17410721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]